News

Clinical Trials Arena48m

Scipher Medicine introduces AI platform to forecast trial failure

Precision immunology company Scipher Medicine has introduced the ClinicalTrialRank.com AI platform to the public.
Clinical Trials Arena1h

Rocket to relaunch rare disease trial after FDA approval

A501, which was placed on hold due to a patient death, will now resume with a reduced dose and altered regimen.
Clinical Trials Arena1h

Neurizon’s ALS expansion data supports NUZ-001 advancement to HEALEY trial

The long-term data supports the drug’s progression into the HEALEY ALS Platform trial, with NUZ-001 dosing set to commence in Q4 2025. This will only begin, however, if the US Food and Drug ...
Clinical Trials Arena21h

Uncertainty remains over FDA ruling on block for China engineering of US cells

The FDA has announced it will no longer accept clinical trials that involve sending US patients cells from US to China for ...
Clinical Trials Arena21h

MTPA’s Radicava shows long-term benefit in ALS trials

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...
Clinical Trials Arena11h

Celldex drops EoE mAb despite meeting primary endpoint

Celldex will stop development of barzolvolimab in eosinophilic esophagitis, but it will continue progressing the drug in ...